Ethyl dirazepate
Chemical compound
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C18H14Cl2N2O3 |
Molar mass | 377.22 g·mol−1 |
3D model (JSmol) |
|
| |
| |
NY (what is this?) (verify) |
Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[2][3][4]
See also
References
- ^ ZA Patent 6804601
- ^ "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ^ "Drugs of the Future". Thomson Reuters. 6 (11). November 1981.
- ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY". Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Archived from the original (PDF) on 27 June 2014. Retrieved 7 December 2009.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Ethyl_dirazepate&oldid=1205244517"